NSEOutcome of Board Meeting6d ago · 27 Aug 2026, 05:26 pm

Outcome of Board Meeting

Laxmi Dental Limited · LAXMIDENTL

✦ AI SummaryResults

Laxmi Dental Limited has informed the Exchange regarding Outcome of Board Meeting held on August 27, 2026, where the Board of Directors approved allotment of 7,911 Equity Shares to eligible employees under Laxmi Dental Stock Option Scheme 2024, proposed variation in the objects of the Initial Public Offering proceeds, and closure of trading window.

Analysis Scores

Earnings Impact2/10
Growth Catalyst3/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Laxmi Dental Limited has informed the Exchange regarding Outcome of Board Meeting held on August 27, 2026.

Attachments (1)

📄

LAXMI_27082026172557_Outcome.pdf

pdf

Download →
View document text
Registered Office: 103, Akruti Arcade, Opposite A H Wadia High School, Near Azad Nagar Metro Station, Andheri (West), Mumbai –400058. Tel: 022 61437991 | Email: info@laxmidentallimited.com | Website: www.laxmidentallimited.com CIN No: L51507MH2004PLC147394 | GST No: 27AABCL0001A1ZL Date: August 27, 2026 Listing Department Listing & Compliance Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, 5th Floor Dalal Street, Mumbai – 400001 Plot No. C/1, “G” Block BSE Scrip Code: 544339 Bandra-Kurla Complex Bandra (E), Mumbai – 400 051 Symbol: LAXMIDENTL Dear Sir(s)/Madam(s), Re: LAXMI DENTAL LIMITED - ISIN: INE0WO601020 Subject: Outcome of Board Meeting held today i.e. Thursday, August 27, 2026. Ref: Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Pursuant to the Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended from time to time (“SEBI Listing Regulations”), we wish to inform you that the Board of Directors, at its meeting held today i.e., Thursday, August 27, 2026, inter-alia, has considered and approved the following: 1. Approved allotment of 7,911/- (Seven Thousand Nine Hundred and Eleven only) Equity Shares of face value of INR 2/- (Rupees Two only) each, to the eligible employees of the Company and its subsidiaries, pursuant to exercise of the options vested with them under Laxmi Dental Stock Option Scheme 2024 (“ESOP 2024”/”Scheme”). Consequent to the aforesaid allotment, the paid-up equity share capital of the Company stands increased as below: Pre-Allotment Post Allotment No. of Equity Shares Face value (in ‘INR’) No. of Equity Shares Face value (in ‘INR’) held held 5,50,21,509 2 5,50,29,420 2 The details and disclosures as required under the Regulation 10(c) SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 are enclosed as Annexure – 1 of this letter. 2. Proposed variation in the objects of the Initial Public Offering (“IPO”) proceeds and extension of timeline for utilization of IPO proceeds (“Proposed Variation”), subject to approval of shareholders’ approval. The details of the Proposed Variation are enclosed herewith as Annexure 2. The Company will make the applicable disclosure upon issuance of the notice for obtaining shareholders’ approval for the proposed variation in the objects and extension of the timeline for utilization of IPO proceeds in due course. Further details of the Proposed Variation will be provided in the explanatory statement attached to the notice. Registered Office: 103, Akruti Arcade, Opposite A H Wadia High School, Near Azad Nagar Metro Station, Andheri (West), Mumbai –400058. Tel: 022 61437991 | Email: info@laxmidentallimited.com | Website: www.laxmidentallimited.com CIN No: L51507MH2004PLC147394 | GST No: 27AABCL0001A1ZL 3. Closure of Trading Window Pursuant to the provisions of the SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time, and in terms of the Company’s Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders, the trading window for dealing in securities of the Company shall remain closed for all Designated Persons, Connected Persons and their immediate relatives from Thursday, August 27, 2026 till 48 hours after the declaration of voting results of the Shareholders’ Meeting (Annual General Meeting) in view of the proposed variation in the objects and extension of the timeline for utilization of IPO proceeds, both of which are subject to the approval of the Shareholders of the Company. The aforesaid closure of the trading window is being communicated to the Designated Persons, their immediate relatives and connected persons in accordance with the Company’s Code of Conduct for Prohibition of Insider Trading. The meeting of the Board of Directors commenced at 04:00 P.M. (IST) and concluded at 04:30 P.M. (IST). The same will be made available on the Company’s website, i.e. www.laxmidentallimited.com Kindly take the same on your record. For Laxmi Dental Limited -------------------------------------------------- Suman Saha Company Secretary and Compliance Officer ICSI Membership Number: A33035 Encl.: As above. Registered Office: 103, Akruti Arcade, Opposite A H Wadia High School, Near Azad Nagar Metro Station, Andheri (West), Mumbai –400058. Tel: 022 61437991 | Email: info@laxmidentallimited.com | Website: www.laxmidentallimited.com CIN No: L51507MH2004PLC147394 | GST No: 27AABCL0001A1ZL Annexure – 1 Statement as per the format prescribed in Part E of Schedule – I under Regulation 10(c) of (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 1. Company name and address of Name: Laxmi Dental Limited Registered Office: CIN: L51507MH2004PLC147394 Registered office Address: Office No. 103, Akruti Arcade, J.P. Road, Opposite A.H. Wadia High School, Andheri West, Mumbai-400058, Maharashtra. 2. Name of the recognised Stock BSE Limited (“BSE”) and Exchanges on which the company's National Stock Exchange of India Limited (“NSE”) shares are listed: 3. Filing date of the statement referred Stock Exchange Date of filing Date of approval in regulation 10(b) of the Securities application and Exchange Board of India (Share Based Employee Benefits and Sweat BSE 12.01.2026 10.04.2026 Equity) Regulations, 2021 with the NSE 12.01.2026 08.04.2026 recognised Stock Exchange: 4. Filing Number, if any : BSE: 256958 NSE: 52967 5. Title of the Scheme pursuant to Laxmi Dental Stock Option Scheme 2024 (“ESOP 2024”/”Scheme”) which shares are issued, if any: 6. Kind of security to be listed: Equity Shares 7. Par value of the shares: INR 2/- per share 8. Date of issue of shares: August 27, 2026 9. Number of shares issued: 7,911 Equity Shares 10. Share Certificate No., if applicable: Not Applicable 11. Distinctive number of the share, if 5,50,21,510 - 5,50,29,420 applicable: 12. ISIN Number of the shares if issued INE0WO601020 in Demat: 13. Exercise price per share: INR 2 per share 14. Premium per share : NA 15. Total issued shares after this issue : 5,50,29,420 Equity Shares 16. Total issued share capital after this INR 11,00,58,840/- issue: 17. Details of any lock-in on the shares : Not applicable 18. Date of expiry of lock-in : Not applicable 19. Whether shares are identical in all All equity shares of the Company allotted pursuant to exercise of respects to existing shares? If not, stock options shall rank pari-passu with the existing equity shares of when will they become identical? : the Company 20. Details of listing fees, if payable : Not applicable Registered Office: 103, Akruti Arcade, Opposite A H Wadia High School, Near Azad Nagar Metro Station, Andheri (West), Mumbai –400058. Tel: 022 61437991 | Email: info@laxmidentallimited.com | Website: www.laxmidentallimited.com CIN No: L51507MH2004PLC147394 | GST No: 27AABCL0001A1ZL Annexure – 2 The details of the Proposed Variation are set out in the table below: (in INR million) Sr. Objects of the IPO Total Money Amount Details of Revised Balance Revised No. amount utilized unutilized variation amount post timeline raised for the as on after Proposed for object August 18, Proposed Variation utilization 2026 Variation Original objects of the IPO as stated in the Prospectus 1. Repayment/prepayment, 229.84 229.84 - No change - - - in full or in part, of certain outstanding borrowings availed by our Company 2. Investment in certain 46.00 46.00 - No change - - - Subsidiaries for the repayment/prepayment, in full or in part, of certain outstanding borrowings 3. Funding the capital 435.07 177.81 257.26 Funds NIL NIL - expenditure reallocated requirements for to newly purchase of new added machinery for our object Company 4. *Investment in our 250.04 26.27 223.77 Funds NIL NIL - Subsidiary, Bizdent reallocated Devices Private Limited, to newly for the capital added expenditure object requirements for the purchase o [Showing first 8,000 characters — download PDF for full document]